| Polyphenols: Mechanisms of Action in Human Health and Disease SK Shebeko, IA Zupanets, OS Popov, OO Tarasenko, AS Shalamay Academic Press, 2018 | 64 | 2018 |
| Effects of quercetin and its combinations on health SK Shebeko, IA Zupanets, OS Popov, OO Tarasenko, AS Shalamay Polyphenols: mechanisms of action in human health and disease, 373-394, 2018 | 29 | 2018 |
| Diclocor is superior to diclofenac sodium and quercetin in normalizing biochemical parameters in rats with collagen-induced osteoarthritis IA Zupanets, SK Shebeko, OS Popov, AS Shalamay Inflammopharmacology 24, 53-57, 2016 | 11 | 2016 |
| The effect of the medication «Diclocor», containing diclofenac and quercetin, on clinico-biochemical parameters in rats with osteoarthritis IA Zupanets, SK Shebeko, OS Popov International Journal of Pharmacy and Pharmaceutical Sciences 7 (9), 101-104, 2015 | 5 | 2015 |
| Pns29 health research and big data in Ukraine: Perspectives and concerns K Ratushna, V Dobrova, O Popov Value in health 22, S767-S768, 2019 | 4 | 2019 |
| Joint Task Force Core Competency Framework Adoption Process at a National Level: A Survey of Ukrainian-Based Clinical Research Professionals VY Dobrova, OS Popov, OV Shtrimaitis, OO Andreeva, OM Proskurnia Therapeutic Innovation & Regulatory Science 56 (5), 814-821, 2022 | 2 | 2022 |
| Shaping of the evidence-based substitution conceptual framework of the original medicines to generic counterparts in Ukraine V Dobrova, O Popov, I Zupanets, K Tkachenko ScienceRise: Pharmaceutical Science 4 (32), 67-77, 2021 | 2 | 2021 |
| N-Acetylglucosamine is the most effective glucosamine derivative for the treatment of membranous nephropathy in rats SK Shebeko, IA Zupanets, OS Popov Die Pharmazie-An International Journal of Pharmaceutical Sciences 74 (11 …, 2019 | 2 | 2019 |
| Äîñë³äæåííÿ âïëèâó ïðåïàðàòó «Äèêëîêîð» íà ñïîíòàííó áîëüîâó ðåàêö³þ â åêñïåðèìåíò³ ÎÑ Ïîïîâ, ÑÊ Øåáåêî, ²À Çóïàíåöü, ÀÑ Øàëàìàé, ÀÑ Ïîïîâ, ... | 2 | 2016 |
| The “Affordable Medicines” reimbursement program in Ukraine: framework assessment and impact evaluation V Dobrova, K Ratushna, O Popov, A Bezruk, I Loboda Value in Health 26 (3), 359-369, 2023 | 1 | 2023 |
| Reimbursement Program" Affordable Medicines" In Ukraine: The Framework Assessment And Impact Evaluation. V Dobrova, K Ratushna, O Popov, A Bezruk, I Loboda Value in Health: the Journal of the International Society for …, 2023 | 1 | 2023 |
| Åêñïåðèìåíòàëüíå äîñë³äæåííÿ ïðîòèçàïàëüíèõ âëàñòèâîñòåé ïðåïàðàòó «Äèêëîêîð» OS Popov, SK Shebeko, OI Shevchenko, AS Shalamay Clinical pharmacy 19 (4), 35-39, 2015 | 1 | 2015 |
| Åêñïåðèìåíòàëüíå äîñë³äæåííÿ ïðîòèçàïàëüíèõ âëàñòèâîñòåé ïðåïàðàòó «Äèêëîêîð» OS Popov, SK Shebeko, OI Shevchenko, AS Shalamay Clinical pharmacy 19 (4), 35-39, 2015 | 1 | 2015 |
| The experimental study of anti-inflammatory properties of the drug “Diclocor” OS Popov, SK Shebeko, OI Shevchenko, AS Shalamay Clin Pharm 19 (4), 35-39, 2015 | 1 | 2015 |
| Morphological study of the effect of the drug “Diclocor” in the course of collagen-induced arthritis in rats OS Popov, IA Zupanets, SK Shebeko Morphologia 9 (3), 58-66, 2015 | 1 | 2015 |
| Morphological study of the effect of the drug “Diclocor” in the course of collagen-induced arthritis in rats OS Popov, IA Zupanets, SK Shebeko Morphologia 9 (3), 58-66, 2015 | 1 | 2015 |
| Analysis of the presence of antidrenergic drugs used in the pharmacotherapy of arterial hypertension in the medical and technological documents OV Tkachova, OO Gerasimova, OS Popov | | 2023 |
| Overview of ukrainian pricing reimbursement model OS Popov, VY Dobrova | | 2023 |
| The study of awareness of Ukrainian clinical research professionals in GCP OS Popov, VY Dobrova, IA Otrishko | | 2023 |
| Pharmacoeconomic analysis of the feasibility of generic substitution in the treatment of epilepsy with carbamazepine OS Popov, VY Dobrova, TY Kolodyezna, SV Misiurova | | 2021 |
